Positron-Emission Tomography

"Positron-Emission Tomography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.

Descriptor ID	D049268
MeSH Number(s)	E01.370.350.350.800.700 E01.370.350.600.350.800.399 E01.370.350.710.800.399 E01.370.350.825.800.399 E01.370.384.730.800.399
Concept/Terms	Positron-Emission Tomography Positron-Emission Tomography Positron Emission Tomography PET Scan PET Scans Scan, PET Scans, PET Tomography, Positron-Emission Tomography, Positron Emission

Below are MeSH descriptors whose meaning is more general than "Positron-Emission Tomography".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Diagnostic Imaging [E01.370.350]
Image Interpretation, Computer-Assisted [E01.370.350.350]
Tomography, Emission-Computed [E01.370.350.350.800]
Positron-Emission Tomography [E01.370.350.350.800.700]
Photography [E01.370.350.600]
Image Enhancement [E01.370.350.600.350]
Tomography, Emission-Computed [E01.370.350.600.350.800]
Positron-Emission Tomography [E01.370.350.600.350.800.399]
Radionuclide Imaging [E01.370.350.710]
Tomography, Emission-Computed [E01.370.350.710.800]
Positron-Emission Tomography [E01.370.350.710.800.399]
Tomography [E01.370.350.825]
Tomography, Emission-Computed [E01.370.350.825.800]
Positron-Emission Tomography [E01.370.350.825.800.399]
Diagnostic Techniques, Radioisotope [E01.370.384]
Radionuclide Imaging [E01.370.384.730]
Tomography, Emission-Computed [E01.370.384.730.800]
Positron-Emission Tomography [E01.370.384.730.800.399]

Below are MeSH descriptors whose meaning is related to "Positron-Emission Tomography".

Below are MeSH descriptors whose meaning is more specific than "Positron-Emission Tomography".

Positron-Emission Tomography
Positron Emission Tomography Computed Tomography

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Positron-Emission Tomography" by people in this website by year, and whether "Positron-Emission Tomography" was a major or minor topic of these publications.

Bar chart showing 255 publications over 21 distinct years, with a maximum of 22 publications in 2008 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	6	13	19
2006	11	8	19
2007	8	13	21
2008	7	15	22
2009	6	8	14
2010	4	14	18
2011	6	15	21
2012	9	8	17
2013	10	12	22
2014	3	8	11
2015	7	8	15
2016	2	7	9
2017	7	10	17
2018	1	5	6
2019	3	3	6
2020	0	4	4
2021	1	1	2
2022	0	3	3
2023	1	3	4
2024	2	2	4
2025	0	1	1

Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles.

Rosenblum JS, Cole Y, Dang D, Lookian PP, Alkaissi H, Patel M, Cappadona AJ, Jha A, Edwards N, Donahue DR, Munasinghe J, Wang H, Knutsen RH, Pappo AS, Lechan RM, Kozel BA, Smirniotopoulos JG, Kim HJ, Vortmeyer A, Miettinen M, Heiss JD, Zhuang Z, Pacak K. Head and neck paraganglioma in Pacak-Zhuang syndrome. JNCI Cancer Spectr. 2025 Jan 03; 9(1).

View in: PubMed
Ivanidze J, Sharbatdaran A, McCalla A, Brandmaier A, Andreopoulou E, Cristofanilli M, Cigler T, Balogun OD, Magge RS, Liechty B, Karakatsanis NA, Nehmeh SA, Agee MA, Jean J, Osborne JR, Beal K, Schwartz TH, Pannullo SC, Knisely JPS, Ramakrishna R. [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases. Eur J Radiol. 2024 Dec; 181:111791.

View in: PubMed
Xu W, Langhans SA, Johnson DK, Stauff E, Kandula VVR, Kecskemethy HH, Averill LW, Yue X. Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2. Int J Mol Sci. 2024 Aug 30; 25(17).

View in: PubMed
Heholt J, Patel R, Vedaei F, Zabrecky G, Wintering N, Monti DA, Wang Z, Newberg AB, Mohamed FB. Simultaneous arterial spin labeling functional MRI and fluorodeoxyglucose PET in mild chronic traumatic brain injury. J Neuroradiol. 2024 Sep; 51(5):101211.

View in: PubMed
Choi W, Jia Y, Kwak J, Werner-Wasik M, Dicker AP, Simone NL, Storozynsky E, Jain V, Vinogradskiy Y. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform. 2024 03; 8:e2300241.

View in: PubMed
Newberg AB, Wintering NA, Hriso C, Vedaei F, Mohamed FB, Gottfried SE, Ross R. Alterations in cerebral glucose metabolism measured by FDG PET in subjects performing a meditation practice based on clitoral stimulation. F1000Res. 2022; 11:1015.

View in: PubMed
Moul JW, Shore ND, Pienta KJ, Czernin J, King MT, Freedland SJ. Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2024 06; 27(2):202-211.

View in: PubMed
Horgan S, Sanghani R, Miller S, Al-Mallah M, Bateman T, Beanlands R, Calnon D, Chareonthaitawee P, Di Carli M, Patel KK, Soman P, Thompson R, Winchester D, Heller G. ASNC model coverage policy: 2023 cardiac positron emission tomography. J Nucl Cardiol. 2023 10; 30(5):2114-2185.

View in: PubMed
Calais J, Eulau SM, Gardner L, Hauke RJ, Kendi AT, Shore ND, Zhao S. Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer. Cancer Treat Rev. 2023 Apr; 115:102524.

View in: PubMed
Chae SY, Park SH, Lee HS, Ahn JH, Kim SB, Jung KH, Kim JE, Ahn SH, Son BH, Lee JW, Ko BS, Kim HJ, Gong G, Oh JS, Park SY, Moon DH. Association between tumor 18F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer. Sci Rep. 2022 05 12; 12(1):7858.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement